Liabilities / Assets
62nd percentile
Higher debt load relative to assets than 62% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.44x
Liabilities / Revenue
59th percentile
Higher debt load relative to revenue than 59% of similar nonprofits.
Net Margin
9th percentile
Higher net margin than 9% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
15th percentile
Faster asset growth than 15% of similar nonprofits.
Revenue Growth
9th percentile
Faster revenue growth than 9% of similar nonprofits.
Balance Sheet
Assets
Down$54,809,165
Down $1,699,132 (-3.0%) from 2013
Net Assets
Down$30,946,218
Down $5,808,704 (-16%) from 2013
Liabilities
Up$23,862,947
Up $4,109,572 (+21%) from 2013
Revenue And Expenses
Revenue
Down$39,884,309
Down $10,243,500 (-20%) from 2013
Expenses
Down$45,243,013
Down $407,423 (-0.9%) from 2013
Net Income
Down-$5,358,704
Down $9,836,077 (-220%) from 2013
Historical Trend
Filing Detail Status
This 2014 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2014 to Dec 31, 2014
Mission and Program Overview
Mission
The prostate cancer foundation (pcf) is a global biomedical research funding foundation committed to ending death and suffering from prostate cancer. Pcf accelerates the world's most promising prostate cancer research with the goal of discovering and developing new precision prevention, earlier detection and genomic medicines for prostate cancer.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2014 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $54,809,165
- Liabilities
- $23,862,947
- Net assets
- $30,946,218
- Revenue
- $39,884,309
- Expenses
- $45,243,013
- Net income
- -$5,358,704